Pathway and mechanism of drug binding to G-protein-coupled receptors
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
How drugs bind to their receptors—from initial association, through drug entry into the binding pocket, to adoption of the final bound conformation, or “pose”—has remained unknown, even for G-protein-coupled receptor modulators, which constitute one-third of all marketed drugs. We captured this pharmaceutically critical process in atomic detail using the first unbiased molecular dynamics simulations in which drug molecules spontaneously associate with G-protein-coupled receptors to achieve final poses matching those determined crystallographically. We found that several beta blockers and a beta agonist all traverse the same well-defined, dominant pathway as they bind to the β 1 - and β 2 -adrenergic receptors, initially making contact with a vestibule on each receptor’s extracellular surface. Surprisingly, association with this vestibule, at a distance of 15 Å from the binding pocket, often presents the largest energetic barrier to binding, despite the fact that subsequent entry into the binding pocket requires the receptor to deform and the drug to squeeze through a narrow passage. The early barrier appears to reflect the substantial dehydration that takes place as the drug associates with the vestibule. Our atomic-level description of the binding process suggests opportunities for allosteric modulation and provides a structural foundation for future optimization of drug–receptor binding and unbinding rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,311
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
The structure and function of G-protein-coupled receptors
Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009) · Nature · doi:10.1038/nature08144 · Cited by 2,534
Structure of a β1-adrenergic G-protein-coupled receptor
Warne, T., Serrano-Vega, M. J., Baker, J. G., Moukhametzianov, R., Edwards, P. C., Henderson, R., Leslie, A. G. W., Tate, C. G., & Schertler, G. F. X. (2008) · Nature · doi:10.1038/nature07101 · Cited by 1,344
GPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function
Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Yao, X.-J., Weis, W. I., Stevens, R. C., et al. (2007) · Science · doi:10.1126/science.1150609 · Cited by 1,336
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063 · cited 1×
“Allosteric GPCR modulators, which bind at sites distinct from the classical orthosteric binding pocket, hold the promise of enhanced selectivity compared to orthosteric GPCR drugs (33).”
BackgroundLigand Binding: Molecular Mechanics Calculation of the Streptavidin-Biotin Rupture Force
Grubmüller, H., Heymann, B., & Tavan, P. (1996) · Science · doi:10.1126/science.271.5251.997 · Cited by 934
Allosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
How Does a Drug Molecule Find Its Target Binding Site?
Shan, Y., Kim, E. T., Eastwood, M. P., Dror, R. O., Seeliger, M. A., & Shaw, D. E. (2011) · Journal of the American Chemical Society · doi:10.1021/ja202726y · Cited by 614 · cited 1×
“Distance and rmsd measurements were computed using the HiMach parallel analysis framework (16).”
MethodSelf-citationNMR spectroscopy brings invisible protein states into focus
Baldwin, A. J., & Kay, L. E. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.238 · Cited by 432
Drug–target residence time: critical information for lead optimization
Lu, H., & Tonge, P. J. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.176 · Cited by 432
Measurement of the millisecond activation switch of G protein–coupled receptors in living cells
Vilardaga, J.-P., Bünemann, M., Krasel, C., Castro, M., & Lohse, M. J. (2003) · Nature Biotechnology · doi:10.1038/nbt838 · Cited by 431
Observation of a dewetting transition in the collapse of the melittin tetramer
Liu, P., Huang, X., Zhou, R., & Berne, B. J. (2005) · Nature · doi:10.1038/nature03926 · Cited by 373
Wacker, D., Fenalti, G., Brown, M. A., Katritch, V., Abagyan, R., Cherezov, V., & Stevens, R. C. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105108q · Cited by 358
Böhm, H., & Klebe, G. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199625881 · Cited by 328
Modification of the binding properties of muscarinic receptors by gallamine.
Stockton, J. M., Birdsall, N. J., Burgen, A. S., & Hulme, E. C. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14327-7 · Cited by 328
Millisecond-scale molecular dynamics simulations on Anton
Shaw, D. E., Dror, R. O., Salmon, J. K., Grossman, J. P., Mackenzie, K. M., Bank, J. A., Young, C., Deneroff, M. M., Batson, B., Bowers, K. J., et al. (2009) · Proceedings of the Conference on High Performance Computing Networking, Storage and Analysis · doi:10.1145/1654059.1654126 · Cited by 294
Self-citationStructure-based discovery of β 2 -adrenergic receptor ligands
Kolb, P., Rosenbaum, D. M., Irwin, J. J., Fung, J. J., Kobilka, B. K., & Shoichet, B. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812657106 · Cited by 288
Weiland, G. A., Minneman, K. P., & Molinoff, P. B. (1979) · Nature · doi:10.1038/281114a0 · Cited by 259
Computer Simulations of the Diffusion of a Substrate to an Active Site of an Enzyme
Sharp, K., Fine, R., & Honig, B. (1987) · Science · doi:10.1126/science.3589666 · Cited by 222
Caron, M. G., & Lefkowitz, R. J. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33597-4 · Cited by 200
A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor
Hurst, D. P., Grossfield, A., Lynch, D. L., Feller, S., Romo, T. D., Gawrisch, K., Pitman, M. C., & Reggio, P. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041590 · Cited by 200
Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding.
Alexander, R. W., Williams, L. T., & Lefkowitz, R. J. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.4.1564 · Cited by 182
Electrostatic funneling of substrate in mitochondrial inner membrane carriers
Wang, Y., & Tajkhorshid, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801786105 · Cited by 139
Isothermal titration calorimetry in drug discovery.
Ward, W., & Holdgate, G. (2001) · Progress in Medicinal Chemistry · doi:10.1016/s0079-6468(08)70097-3 · Cited by 128
A Ligand Channel through the G Protein Coupled Receptor Opsin
Hildebrand, P. W., Scheerer, P., Park, J. H., Choe, H.-W., Piechnick, R., Ernst, O. P., Hofmann, K. P., & Heck, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004382 · Cited by 124
Ligand Entry and Exit Pathways in the β2-Adrenergic Receptor
Wang, T., & Duan, Y. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.093 · Cited by 98
Mechanism of Fast Peptide Recognition by SH3 Domains
Ahmad, M., Gu, W., & Helms, V. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200801856 · Cited by 89
Swinney, D. C. (2008) · Pharmaceutical Medicine · doi:10.1007/bf03256679 · Cited by 79
Time-resolved structural studies of protein reaction dynamics: a smorgasbord of X-ray approaches
Westenhoff, S., Nazarenko, E. S., Malmerberg, E., Davidsson, J., Katona, G., & Neutze, R. (2010) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767309054361 · Cited by 52
Binding of Orthosteric Ligands to the Allosteric Site of the M2 Muscarinic Cholinergic Receptor
Redka, D. S., Pisterzi, L. F., & Wells, J. W. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048074 · Cited by 31
Cited by
Molecular Dynamics Simulation for All
Hollingsworth, S. A., & Dror, R. O. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.011 · Cited by 3,257
Self-citationMolecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
Role of Molecular Dynamics and Related Methods in Drug Discovery
De Vivo, M., Masetti, M., Bottegoni, G., & Cavalli, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01684 · Cited by 1,297
Biomolecular Simulation: A Computational Microscope for Molecular Biology
Dror, R. O., Dirks, R. M., Grossman, J. P., Xu, H., & Shaw, D. E. (2012) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-042910-155245 · Cited by 1,198
Self-citationProtein 3D Structure Computed from Evolutionary Sequence Variation
Marks, D. S., Colwell, L. J., Sheridan, R., Hopf, T. A., Pagnani, A., Zecchina, R., & Sander, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028766 · Cited by 1,144
“such as BPTI and WW domains [29,30].”
Metadata
- Authors
- Dror, R. O., Pan, A. C., Arlow, D. H., Borhani, D. W., Maragakis, P., Shan, Y., Xu, H., & Shaw, D. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2011-07-21
- Volume
- 108
- Issue
- 32
- Pages
- 13118-13123
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2049617698
- Cited by
- 730
- References
- 32
- FWCI
- 19.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.